The results showed that serum levels of PAK6, ProGRP, and NSE significantly decreased following SCLC treatment (p < 0.001, Figs. 4A–4C), while CEA and CA19-9 levels showed no significant changes (Figs. 4D, 4E). This evidence concerns the gene GRP and small cell lung carcinoma.